IBDEI0LF ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10487,2)
 ;;=^328501
 ;;^UTILITY(U,$J,358.3,10488,0)
 ;;=428.43^^64^684^51
 ;;^UTILITY(U,$J,358.3,10488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10488,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,10488,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,10488,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,10489,0)
 ;;=396.3^^64^684^10
 ;;^UTILITY(U,$J,358.3,10489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10489,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,10489,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,10489,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,10490,0)
 ;;=429.9^^64^684^28
 ;;^UTILITY(U,$J,358.3,10490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10490,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,10490,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,10490,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,10491,0)
 ;;=453.79^^64^684^27
 ;;^UTILITY(U,$J,358.3,10491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10491,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,10491,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,10491,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,10492,0)
 ;;=453.89^^64^684^1
 ;;^UTILITY(U,$J,358.3,10492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10492,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,10492,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,10492,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,10493,0)
 ;;=454.2^^64^684^85
 ;;^UTILITY(U,$J,358.3,10493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10493,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,10493,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,10493,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,10494,0)
 ;;=397.1^^64^684^74
 ;;^UTILITY(U,$J,358.3,10494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10494,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,10494,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,10494,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,10495,0)
 ;;=397.0^^64^684^75
 ;;^UTILITY(U,$J,358.3,10495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10495,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,10495,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,10495,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,10496,0)
 ;;=414.3^^64^684^17
 ;;^UTILITY(U,$J,358.3,10496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10496,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,10496,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,10496,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,10497,0)
 ;;=414.4^^64^684^16
 ;;^UTILITY(U,$J,358.3,10497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10497,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,10497,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,10497,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,10498,0)
 ;;=425.11^^64^684^60
 ;;^UTILITY(U,$J,358.3,10498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10498,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,10498,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,10498,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,10499,0)
 ;;=425.18^^64^684^59
 ;;^UTILITY(U,$J,358.3,10499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10499,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,10499,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,10499,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,10500,0)
 ;;=V12.55^^64^684^54
 ;;^UTILITY(U,$J,358.3,10500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10500,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,10500,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,10500,2)
 ;;=^340615
